Trademark: 90681229
Word
LUGENE
Status Date
Thursday, March 28, 2024
Filing Date
Thursday, April 29, 2021
Published for Opposition
Tuesday, February 1, 2022
44 Medical information services, namely, providing reports and information relating to disease activity in individuals suffering from autoimmune diseases, cardiovascular disease, inflammatory diseases, neurological diseases, infectious diseases and oncological diseases based on their genetic profiles and gene expression; Providing reports and information relating to the best drug therapies and treatment options for individuals with autoimmune diseases, cardiovascular disease, inflammatory diseases, neurological diseases, infectious diseases and oncological diseases based on their genetic profile and gene expression
The mark consists of the word LuGENE with capital letters L, G, E, N, and E. The u is lowercase.
Mar 29, 2024
Notice Of Approval Of Extension Request E-Mailed
Mar 28, 2024
Sou Extension 4 Granted
Mar 28, 2024
Sou Extension 4 Filed
Mar 28, 2024
Sou Teas Extension Received
Sep 29, 2023
Notice Of Approval Of Extension Request E-Mailed
Sep 27, 2023
Sou Extension 3 Granted
Sep 27, 2023
Sou Extension 3 Filed
Sep 27, 2023
Sou Teas Extension Received
Mar 30, 2023
Notice Of Approval Of Extension Request E-Mailed
Mar 28, 2023
Sou Extension 2 Granted
Mar 28, 2023
Sou Extension 2 Filed
Mar 28, 2023
Sou Teas Extension Received
Sep 27, 2022
Notice Of Approval Of Extension Request E-Mailed
Sep 23, 2022
Sou Extension 1 Granted
Sep 23, 2022
Sou Extension 1 Filed
Sep 23, 2022
Sou Teas Extension Received
Mar 29, 2022
Noa E-Mailed - Sou Required From Applicant
Feb 1, 2022
Official Gazette Publication Confirmation E-Mailed
Feb 1, 2022
Published For Opposition
Jan 12, 2022
Notification Of Notice Of Publication E-Mailed
Dec 29, 2021
Approved For Pub - Principal Register
Dec 29, 2021
Assigned To Examiner
Aug 3, 2021
New Application Office Supplied Data Entered
May 3, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
